Aurobindo Pharma Inc recalls Mirtazapine tablets in US

The product is being recalled due to a label error on declared strength. Bottles labelled as Mirtazapine 7.5 mg may contain 15 mg tablets, as per the company's announcement posted on the website of the United States Food and Drug Administration (USFDA).

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37vDnuA
via IFTTT